Citius Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Citius Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CTXR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001506251
Board of directors
-
Carol Webb · DirectorSince 2023
-
Dennis M. Mcgrath · DirectorSince 2023
-
Eugene Myron Holuka · DirectorSince 2023
-
Leonard L. Mazur · Director · Chief Executive OfficerSince 2023
-
Myron Z. Holubiak · Director · Vice ChairmanSince 2023
-
Robert Joseph Smith · DirectorSince 2024
-
Suren G. Dutia · DirectorSince 2023
Chief executives
Leonard L. Mazur
· Chief Executive Officer
Dates unknown
Board connections
7 of this board's directors also sit on 3 other boards.
- via Carol Webb, Dennis M. Mcgrath, Eugene Myron Holuka, Leonard L. Mazur, Myron Z. Holubiak, Robert Joseph Smith and Suren G. Dutia
- via Leonard L. Mazur
- via Dennis M. Mcgrath
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2024 | Eugene Myron Holuka Director | Option exercise | +2,415 | $0.02 | $48 |
| Mar 13, 2024 | Eugene Myron Holuka Director | Shares withheld for tax | −48 | $0.75 | $36 |
| Mar 4, 2024 | Carol Webb Director | Option exercise | +12,071 | $0.02 | $241 |
| Mar 4, 2024 | Carol Webb Director | Shares withheld for tax | −236 | $0.77 | $182 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.